Policlinico Universitario Campus Biomedico di Roma

Roma 128

1 studies enrolling now · 6 studies all time

What they study most

Advanced Cholangiocarcinoma, Carotid Stenosis, FGFR2 Gene Mutation, Follicular Lymphoma, Gastric Cancer, Pancreatic Neoplasms, Systemic Lupus Erythematosus

Studies at this site

• A Study of Obexelimab in Patients With Systemic Lupus Erythematosus — Recruiting now
• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
• Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients — Status unconfirmed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) — Completed